Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05203198 · ClinicalTrials.gov registry record · NA

The PATHway Study: Primary Care Based Depression Prevention in Adolescents

A NA study of Depression and Mental Disorder in Adolescence, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
400
Enrollment target
6
Study locations

NCT05203198: Active NA study of Depression and Mental Disorder in Adolescence, sponsored by University of Illinois at Chicago.

NCT05203198 is a NA study of Depression and Mental Disorder in Adolescence that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 400 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (49% lower). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05203198, a NA study of Depression and Mental Disorder in Adolescence, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
6
Study locations

Study Summary

Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT). The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.

Primary Outcome

Time will be measured to nearest minute for all intervention related activities including initial screening, engagement phone calls, use of CATCH-IT. Time will be measured from adolescent, family, practice, community center, healthcare organization, health system perspective. For time that cannot be directly measured by study staff, the investigators will sample direct observation or questionnaires to capture time required for health system related activities such as screening and engagement.

Interventions

  • BEHAVIORAL Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

Study Locations (6)

Illinois

  • Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
  • UI Health - Chicago
  • University of Chicago Comer Children's Hospital - Chicago
  • Northshore University HealthSystem - Glenview
  • Advocate Aurora Health - Park Ridge

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2022-02-01
Est. Completion 2026-10-31
Phase NA
University of Illinois at Chicago

430 total trials

What the registry record for NCT05203198 still lists

NCT05203198 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (49% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training is the first listed.

NCT05203198 lists 6 locations in 2 states (Illinois, Texas).

Frequently Asked Questions

What is clinical trial NCT05203198 about?

NCT05203198 is a clinical study titled "The PATHway Study: Primary Care Based Depression Prevention in Adolescents". Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," ...

What is the current status of trial NCT05203198?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2022-02-01. Estimated completion is 2026-10-31.

What conditions does trial NCT05203198 study?

This clinical trial studies the following conditions: Depression, Mental Disorder in Adolescence.

What interventions are being tested in trial NCT05203198?

The interventions under investigation include: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05203198?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05203198 being conducted?

This trial has 6 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05203198's enrollment target sits among peer trials

400 107th of 679 higher than 568 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05203198, the US trial registry maintained by the National Library of Medicine. NCT05203198 (mid enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.